Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Innovative Medical |
---|---|
Information provided by: | Innovative Medical |
ClinicalTrials.gov Identifier: | NCT00469157 |
To assess the compatibility of Optive with refractive surgery (PRK and LASIK) post-operatively.
Condition | Intervention | Phase |
---|---|---|
Dry Eye Syndromes |
Drug: Optive |
Phase IV |
Study Type: | Interventional |
Study Design: | Supportive Care, Non-Randomized, Open Label, Single Group Assignment |
Official Title: | Refractive Surgery and Optive Compatibility Study |
Enrollment: | 92 |
Study Start Date: | May 2007 |
Study Completion Date: | April 2008 |
Primary Completion Date: | April 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1. |
Drug: Optive
Optive 30ml- (in the eye) Instill one in each eye twice daily starting one week after surgery
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Use of systemic medications with ocular drying sequelae:
Responsible Party: | TLC ( Loren Rude, OD ) |
Study ID Numbers: | 5303 |
Study First Received: | May 2, 2007 |
Last Updated: | April 16, 2008 |
ClinicalTrials.gov Identifier: | NCT00469157 History of Changes |
Health Authority: | United States: Institutional Review Board |
compatibility of Optive after PRK or LASIK |
Eye Diseases Lacrimal Apparatus Diseases Dry Eye Syndromes |
Pathologic Processes Disease Eye Diseases |
Syndrome Lacrimal Apparatus Diseases Dry Eye Syndromes |